Literature DB >> 9681843

Pathology of MEN-1: morphology, clinicopathologic correlations and tumour development.

P Komminoth1, P U Heitz, G Klöppel.   

Abstract

Multiple endocrine neoplasia type 1 (MEN-1) is an inherited syndrome which is characterized by the occurrence of neoplastic lesions in the parathyroids, the pancreas, duodenum, anterior pituitary and, less commonly, also in the stomach, thymus and lung. Its genetic defect has recently been identified and appears to involve a new type of tumour suppressor gene called mu on chromosome 11q13. In this overview, we will summarize the morphological features of the MEN-1 phenotype, discuss its clinicopathologic profile and prognosis and outline the recent findings on the molecular pathology of this syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9681843     DOI: 10.1046/j.1365-2796.1998.00274.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

Review 1.  Multiple endocrine neoplasia type 1.

Authors:  M L Brandi
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  [Tumors of the endocrine pancreas].

Authors:  M Anlauf; B Sipos; G Klöppel
Journal:  Pathologe       Date:  2005-02       Impact factor: 1.011

Review 3.  Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.

Authors:  Jeffrey A Norton; Robert T Jensen
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

Review 4.  [Neuroendocrine tumors of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

Review 5.  [Tumors of the endocrine pancreas].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

6.  Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1).

Authors:  Takamasa Nishiuchi; Hitomi Imachi; Koji Murao; Mako Fujiwara; Tomie Muraoka; Fumi Kikuchi; Yukiko Nishiuchi; Yoshio Kushida; Reiji Haba; Toshihiko Ishida
Journal:  Endocrine       Date:  2009-04-07       Impact factor: 3.633

7.  Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1).

Authors:  G Berglund; A Lidén; M G Hansson; K Oberg; P O Sjöden; K Nordin
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 8.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

9.  Human Insulinomas: Clinical, Cellular, and Molecular Aspects.

Authors:  Paul Komminoth; Philipp U. Heitz; Jürgen Roth
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

10.  Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.

Authors:  William G Dilley; Somasundaram Kalyanaraman; Sulekha Verma; J Perren Cobb; Jason M Laramie; Terry C Lairmore
Journal:  Mol Cancer       Date:  2005-02-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.